Effects of BMS-186716, a new dual metalloprotease inhibitor, on pharmacodynamic markers of neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE) activity in healthy men

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 2, 1997, Pages 230-

  Vesterqvist, O ^a   Liao, W ^a   Manning, J A ^a   Uderman, H ^b   Delaney, C ^a   Beierle, F ^a   Swanson, B N ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001643315     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)